Citation: | GUO Jia-jia, MA Sheng-yin, LIU Li-hua, GAO Jun, GONG Feng. Risk factors of cardiovascular disease in maintenance haemodialysis patients[J]. Chinese Journal of General Practice, 2022, 20(6): 978-981. doi: 10.16766/j.cnki.issn.1674-4152.002503 |
[1] |
陈洁, 陈妙, 应一樱, 等. 冠状动脉钙化积分对于透析患者心血管事件发生风险的预测价值[J]. 中华全科医学, 2019, 17(11): 1856-1859. doi: 10.16766/j.cnki.issn.1674-4152.001074
CHEN J, CHEN M, YING Y Y, et al. Predictive value of coronary artery calcification scores on the risk of cardiovascular events in dialysis patients[J]. Chinese Journal of General Practice, 2019, 17(11): 1856-1859. doi: 10.16766/j.cnki.issn.1674-4152.001074
|
[2] |
COZZOLINO M, GALASSI A, PIVARI F, et al. The cardiovascular burden in end-stage renal disease[J]. Contrib Nephrol, 2017, 191(1): 44-57.
|
[3] |
OTSUKA K, NAKANISHI K, SHIMADA K, et al. Associations of sensitive cardiac troponin-I with left ventricular morphology, function and prognosis in end-stage renal disease patients with preserved ejection fraction[J]. Heart Vessels, 2018, 33(11): 1334-1342. doi: 10.1007/s00380-018-1192-7
|
[4] |
张琨, 王少亭, 胡晓舟, 等. 维持性血液透析患者并发心血管疾病危险因素分析[J]. 山东医药, 2017, 57(4): 82-84. https://www.cnki.com.cn/Article/CJFDTOTAL-SDYY201704028.htm
ZHANG K, WANG S T, HU X Z, et al. Risk factors for concurrent cardiovascular disease in patients on maintenance hemodialysis[J]. Shandong Medicine, 2017, 57(4): 82-84. https://www.cnki.com.cn/Article/CJFDTOTAL-SDYY201704028.htm
|
[5] |
YU L, LI H, WANG S X. Serum magnesium and mortality in maintenance hemodialysis patients[J]. Blood Purif, 2017, 43(1-3): 31-36. doi: 10.1159/000451052
|
[6] |
WU L, CAI K, LUO Q, et al. Baseline serum magnesium level and its variability in maintenance hemodialysis patients: Associations with mortality[J]. Kidney Blood Press Res, 2019, 44(2): 222-232. doi: 10.1159/000498957
|
[7] |
李清, 姚曦, 陈江华, 等. 血镁水平对维持性血液透析患者死亡率的影响[J]. 中华肾脏病杂志, 2020, 36(11): 817-823. https://www.cnki.com.cn/Article/CJFDTOTAL-SHSB202106003.htm
LI Q, YAO X, CHEN J H, et al. Effect of blood magnesium level on mortality in maintenance hemodialysis patients[J]. Chinese Journal of Nephrology, 2020, 36(11): 817-823. https://www.cnki.com.cn/Article/CJFDTOTAL-SHSB202106003.htm
|
[8] |
张艳, 黄琳, 李慧, 等. 维持性血液透析患者血镁水平与心脑血管死亡的关系[J]. 中国血液净化, 2021, 20(11): 732-736. doi: 10.3969/j.issn.1671-4091.2021.11.003
ZHANG Y, HUANG L, LI H, et al. The relationship between blood magnesium level and cardiovascular and cerebrovascular death in maintenance hemodialysis patients[J]. China Blood Purification, 2021, 20(11): 732-736. doi: 10.3969/j.issn.1671-4091.2021.11.003
|
[9] |
MAESATO K, OHTAKE T, MOCHIDA Y, et al. Correlation of hippocampal atrophy with hyperhomocysteinemia in hemodialysis patients: An exploratory pilot study[J]. PLoS One, 2017, 12(4): e0175102. doi: 10.1371/journal.pone.0175102
|
[10] |
葛君, 汪朝晖, 宣玲. 高血压患者血清hs-CRP、Hcy及UA水平与颈动脉粥样硬化的相关性研究[J]. 中华全科医学, 2019, 17(7): 1138-1141. doi: 10.16766/j.cnki.issn.1674-4152.000884
GE J, WANG Z H, XUAN L. Correlation between serum hs-CRP, Hcy and UA levels and carotid atherosclerosis in hypertensive patients[J]. Chinese Journal of General Practice, 2019, 17(7): 1138-1141. doi: 10.16766/j.cnki.issn.1674-4152.000884
|
[11] |
EPIFANIO A P S, BALBINO K P, RIBEIRO S M R, et al. Clinical-nutritional, inflammatory and oxidative stress predictors in hemodialysis mortality: A review[J]. Nutr Hosp, 2018, 35(2): 461-468.
|
[12] |
MACHOWSKA A, SUN J, QURESHI A R, et al. Plasma pentosidine and its association with mortality in patients with chronic kidney disease[J]. PLoS One, 2016, 11(10): e0163826. doi: 10.1371/journal.pone.0163826
|
[13] |
朱士彦, 陈剑泉, 罗承志, 等. 维持性血液透析患者微炎症反应及网膜素-1与冠心病的相关性研究[J]. 临床肾脏病杂志, 2017, 17(7): 407-410. https://www.cnki.com.cn/Article/CJFDTOTAL-LCSB201707006.htm
ZHU S Y, CHEN J Q, LUO C Z, et al. Microinflammaterial response and correlation between omentosin-1 and coronary heart disease in patients on maintenance hemodialysis[J]. Journal of Clinical Nephrology, 2017, 17(7): 407-410. https://www.cnki.com.cn/Article/CJFDTOTAL-LCSB201707006.htm
|
[14] |
宋培. CysC、IL-6及LVEF对维持性血液透析患者发生不良心血管事件的预测价值[J]. 中国实验诊断学, 2020, 24(11): 1762-1765. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSZD202011002.htm
SONG P. Predictive value of CysC, IL-6 and LVEF in the occurrence of adverse cardiovascular events in patients on maintenance hemodialysis[J]. Chinese Journal of Laboratory Diagnostics, 2020, 24(11): 1762-1765. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSZD202011002.htm
|
[15] |
SHEN G, HUANG J Y, YU Y L, et al. J-shaped association between serum uric acid and acute coronary syndrome in patients with essential hypertension[J]. Postgrad Med J, 2020, 96(1132): 73-78. doi: 10.1136/postgradmedj-2019-136650
|
[16] |
李娜. 维持性血液透析患者血尿酸水平与心血管疾病的关系研究[J]. 中国当代医药, 2020, 27(23): 17-20. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGUD202023005.htm
LI N. The relationship between blood uric acid level and cardiovascular disease in maintenance hemodialysis patients[J]. Chinese Contemporary Medicine, 2020, 27(23): 17-20. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGUD202023005.htm
|
[17] |
BULBUL M C, DAGEL T, AFSAR B, et al. Disorders of lipid metabolism in chronic kidney disease[J]. Blood Purif, 2018, 46(2): 144-152. doi: 10.1159/000488816
|
[18] |
VOSKAMP P W M, VAN DIEPEN M, DEKKER F W, et al. Dyslipidemia and risk of renal replacement therapy or death in incident pre-dialysis patients[J]. Sci Rep, 2018, 8(1): 3130.
|
[19] |
TAHERI S, BARADARAN A, ALIAKBARIAN M, et al. Level of inflammatory factors in chronic hemodialysis patients with and without cardiovascular disease[J]. J Res Med Sci, 2017, 22(1): 47.
|